Rapid News Brief
Church & Dwight reported on Oct. 30, 2026, that third-quarter sales increased 1% to $1.60 billion, with volume gains outpacing pricing as the household and personal-care company moved its annual organic-growth target to the top of its previous range.
Investing.com reported that revenue exceeded analysts’ $1.58 billion forecast. Adjusted earnings reached 92 cents a share, above the 90-cent consensus estimate and up from 81 cents a year earlier. Reported earnings, a separate accounting measure, were 89 cents a share, compared with 75 cents.
Volume and online channels
Organic sales rose 5.1%, compared with management’s prior 3% forecast. Volume contributed 4.6 percentage points, while pricing and product mix contributed 0.5 points. Domestic consumer organic sales increased 4.4%; international consumer organic sales rose 7.8%.
In its results announcement, the company identified TheraBreath mouthwash and toothpaste among its domestic growth drivers. It said global e-commerce revenue increased 20%, taking online sales to 25.9% of total consumer sales. That share applies to the consumer business, not all group revenue.
Marketing expense totaled about $191 million, or 11.9% of sales, down 0.9 percentage points from the previous year. Those figures describe company-wide spending; they do not establish the effectiveness of any particular campaign. Gross margin rose 1.7 percentage points to 46.8%, the company reported.
A tighter annual forecast
For the full year, management expects marketing to represent approximately 11% of sales. It also retained its operating cash flow forecast of about $1.175 billion.
Church & Dwight now expects approximately 5% organic sales growth for 2026, the upper end of its previous 4%-5% range. It narrowed expected adjusted earnings growth to about 7% from 6%-8%, rather than increasing the top of that range.
Reported sales growth is forecast at approximately 0.5%, within the previous flat-to-1% range. Management projects roughly 4% organic growth in the fourth quarter. These are company expectations, not completed results. The distinction matters for commercial planning: stronger comparable demand does not mean that every reported-sales or profit target has increased.